Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine 2 maart 2021NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021 26 februari 2021NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesReferrals EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) 26 februari 2021NewsHumanCOVID-19Medicines First oral treatment for spinal muscular atrophy (SMA) recommended for approval 26 februari 2021NewsHumanMedicines Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers 25 februari 2021NewsHumanCOVID-19Regulatory and procedural guidanceVaccines International cooperation to align approaches for regulation of COVID-19 vaccines and medicines 25 februari 2021NewsHumanCOVID-19MedicinesVaccines EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19 24 februari 2021NewsHumanCOVID-19Medicines EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen 23 februari 2021NewsHumanCOVID-19 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 2021 19 februari 2021NewsVeterinaryMedicines Precautionary marketing suspension of thalassaemia medicine Zynteglo 17 februari 2021News 1 … 71 72 73 74 75 Page 75 of 385 76 77 78 79 … 385
EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine 2 maart 2021NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021 26 februari 2021NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesReferrals
EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) 26 februari 2021NewsHumanCOVID-19Medicines
First oral treatment for spinal muscular atrophy (SMA) recommended for approval 26 februari 2021NewsHumanMedicines
Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers 25 februari 2021NewsHumanCOVID-19Regulatory and procedural guidanceVaccines
International cooperation to align approaches for regulation of COVID-19 vaccines and medicines 25 februari 2021NewsHumanCOVID-19MedicinesVaccines
EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19 24 februari 2021NewsHumanCOVID-19Medicines
EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen 23 februari 2021NewsHumanCOVID-19
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 2021 19 februari 2021NewsVeterinaryMedicines